Table A.13
Median Age At Start Of Esrd Therapy
By Year, By Race, Sex, and Primary Disease Causing ESRD

------------------------------------------------------------------------------------------------
|                                  | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 |
|----------------------------------+------+------+------+------+------+------+------+------+------+------|
|Age              0-19             |  15.0|  15.0|  15.0|  15.0|  14.0|  15.0|  14.0|  14.0|  14.0|  14.0|
|                 20-44            |  35.0|  35.0|  35.0|  35.0|  36.0|  36.0|  36.0|  36.0|  36.0|  37.0|
|                 45-64            |  57.0|  57.0|  57.0|  57.0|  57.0|  57.0|  56.0|  56.0|  56.0|  56.0|
|                 65-74            |  69.0|  69.0|  69.0|  69.0|  69.0|  69.0|  69.0|  69.0|  69.0|  70.0|
|                 75 plus          |  78.0|  78.0|  79.0|  79.0|  79.0|  79.0|  79.0|  79.0|  79.0|  79.0|
|Disease          1 Diabetes       |  59.0|  59.0|  60.0|  61.0|  61.0|  62.0|  62.0|  62.0|  62.0|  62.0|
|                 2 Hypertension   |  66.0|  67.0|  67.0|  68.0|  68.0|  68.0|  69.0|  68.0|  69.0|  69.0|
|                 3 Glomeruloneph. |  52.0|  52.0|  53.0|  53.0|  54.0|  54.0|  54.0|  54.0|  53.0|  53.0|
|                 4 Cystic Kidney  |  55.0|  53.0|  53.5|  54.0|  54.0|  54.0|  53.0|  54.0|  53.0|  53.0|
|                 5 Other Urologic |  68.0|  68.0|  69.0|  67.0|  62.0|  64.0|  62.0|  63.0|  65.0|  65.0|
|                 6 Other Cause    |  56.0|  56.0|  57.0|  56.0|  58.0|  58.0|  57.0|  56.0|  56.0|  57.0|
|                 7 Unknown Cause  |  64.0|  65.0|  65.0|  65.0|  65.0|  65.0|  65.0|  64.0|  66.0|  66.0|
|                 8 Missing Cause  |  58.0|  58.0|  64.0|  63.0|  63.0|  65.0|  69.0|  65.0|  66.0|  49.0|
|Race             1 Native Amer.   |  57.0|  57.0|  59.0|  58.0|  58.0|  60.0|  60.0|  58.0|  58.0|  57.0|
|                 2 Asian          |  58.0|  58.5|  60.0|  60.0|  61.0|  61.0|  62.0|  62.0|  62.0|  63.0|
|                 3 Black          |  58.0|  57.0|  58.0|  59.0|  59.0|  59.0|  59.0|  58.0|  57.0|  57.0|
|                 4 White          |  62.0|  63.0|  64.0|  64.0|  65.0|  65.0|  66.0|  65.0|  65.0|  66.0|
|                 5 Unknown        |  64.0|  64.0|  72.0|  72.0|  71.0|  71.0|  72.0|  68.0|  70.0|  56.5|
|                 9 Other          |  55.5|  56.0|  56.0|  45.5|  45.5|  57.0|  61.0|  56.0|  56.0|  56.0|
|Sex              Female           |  62.0|  62.0|  63.0|  63.0|  64.0|  64.0|  65.0|  64.0|  64.0|  64.0|
|                 Male             |  60.0|  60.0|  61.0|  61.0|  62.0|  62.0|  63.0|  62.0|  62.0|  62.0|
|Total            Total            |  61.0|  61.0|  62.0|  62.0|  63.0|  63.0|  64.0|  63.0|  63.0|  63.0|
----------------------------------------------------------------------------------------------------------
 
 
 
Table A.14
 Mean Age At Start Of Esrd Therapy
By Year, By Race, Sex, and Primary Disease Causing ESRD

------------------------------------------------------------------------------------------------
|                                  | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 |
|----------------------------------+------+------+------+------+------+------+------+------+------+------|
|Age              0-19             |  12.8|  12.9|  13.1|  12.7|  12.3|  12.9|  12.5|  12.7|  12.2|  12.3|
|                 20-44            |  34.2|  34.2|  34.3|  34.6|  34.9|  34.9|  34.9|  34.9|  35.2|  35.4|
|                 45-64            |  56.1|  56.1|  56.0|  56.0|  56.0|  55.9|  55.8|  55.7|  55.6|  55.5|
|                 65-74            |  69.2|  69.3|  69.3|  69.3|  69.3|  69.4|  69.4|  69.5|  69.5|  69.6|
|                 75 plus          |  79.2|  79.3|  79.5|  79.6|  79.5|  79.7|  79.8|  79.7|  79.8|  79.9|
|Disease          1 Diabetes       |  56.1|  56.9|  57.3|  58.3|  58.9|  59.3|  59.7|  60.0|  60.3|  60.8|
|                 2 Hypertension   |  63.5|  63.7|  64.1|  64.5|  64.9|  64.9|  65.2|  65.0|  64.8|  65.0|
|                 3 Glomeruloneph. |  50.7|  50.7|  51.3|  51.7|  52.4|  52.3|  52.3|  52.8|  52.1|  52.8|
|                 4 Cystic Kidney  |  54.1|  53.6|  53.5|  54.0|  53.6|  54.4|  54.2|  54.8|  53.7|  54.3|
|                 5 Other Urologic |  61.2|  61.7|  62.8|  60.8|  55.2|  56.5|  55.8|  56.5|  59.2|  59.5|
|                 6 Other Cause    |  51.3|  51.5|  52.3|  51.9|  53.3|  54.2|  53.4|  53.1|  53.2|  54.1|
|                 7 Unknown Cause  |  59.6|  60.0|  60.2|  59.6|  59.4|  59.6|  59.2|  58.8|  61.1|  61.0|
|                 8 Missing Cause  |  54.9|  54.9|  60.9|  59.9|  58.7|  61.6|  66.3|  59.8|  61.4|  49.6|
|Race             1 Native Amer.   |  54.6|  54.7|  56.9|  56.2|  56.2|  58.4|  58.1|  56.2|  56.3|  56.2|
|                 2 Asian          |  55.5|  56.1|  55.5|  56.5|  57.4|  57.2|  58.1|  58.7|  59.7|  60.0|
|                 3 Black          |  55.2|  55.0|  55.3|  55.9|  56.2|  56.4|  56.5|  56.1|  55.6|  55.8|
|                 4 White          |  58.0|  58.7|  59.4|  59.9|  60.6|  61.1|  61.6|  61.7|  61.7|  62.2|
|                 5 Unknown        |  56.9|  60.1|  70.8|  71.3|  70.3|  69.4|  70.4|  64.3|  67.7|  51.8|
|                 9 Other          |  52.5|  52.5|  51.1|  43.3|  45.4|  53.6|  54.8|  51.4|  53.2|  53.1|
|Sex              Female           |  58.2|  58.4|  59.3|  59.7|  60.3|  60.6|  61.2|  60.8|  60.7|  60.8|
|                 Male             |  56.2|  56.7|  57.4|  57.8|  58.2|  58.8|  59.0|  58.9|  58.7|  59.2|
|Total            Total            |  57.1|  57.5|  58.3|  58.7|  59.2|  59.6|  60.0|  59.8|  59.6|  59.9|
----------------------------------------------------------------------------------------------------------
 
 
 
 
 
 
 

Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.
* Values for cells with fewer than 10 patients are suppressed.


Table A.15
Incidence Of Reported ESRD Therapy
Median Age At Incidence, Sex, Race, and One Year Transplant and Death Status
By Detailed Primary Disease, For All Patients, 1992-1996
                                                                                                  %    % Tran  % Died
                                           Total      %    Median    %      %      %      %    Native  First   First
Primary Disease Groups                    Patients  Incid   Age    Males  White  Black  Asian  Amer.    Year    Year

All ESRD, (reference)                     332,459   100.0    63     53.2  63.9   29.4    3.1    1.5      5.2    21.5 
Diabetes                                  130,473    40.4    62     47.4  64.2   28.5    3.3    2.4      3.6    20.6 
. Type 1, juvenile type                    46,100    14.3    57     49.3  70.2   24.9    2.4    1.6      7.3    19.2 
. Type 2, adult-onset or unspec. type      84,373    26.1    64     46.3  60.9   30.5    3.8    2.9      1.6    21.4 
Glomerulonephritis                         36,499    11.3    53     60.8  68.0   24.1    5.0    1.2     11.3    12.3 
. Focal glomerulosclerosis, focal GN        6,497     2.0    44     62.8  57.7   37.4    2.7    1.0     13.8     8.2 
. Membranous nephropathy                    1,554     0.5    57     66.5  71.4   24.2    2.3    1.1     10.9     9.8 
. Membranoproliferative GN, types 1&2       1,284     0.4    45     60.4  74.2   16.7    5.5    1.7     17.9     7.9 
. IgA nephropathy, Bergers disease          1,080     0.3    40     69.6  74.0    8.5   12.4    1.9     19.0     4.5 
. IgM nephropathy                             121     0.0    42     66.1  71.1   10.7   13.2    0.8     28.1     3.3 
. Rapidly progressive GN                    1,336     0.4    61     52.0  80.2   12.9    4.0    1.5      9.0    15.5 
. Goodpastures Syndrome                       780     0.2    64     47.2  89.4    7.1    1.8    1.2      6.0    24.5 
. Post infectious GN, SBE                     214     0.1    54     61.7  75.2   19.2    2.3    1.9      8.4    14.0 
. Glomerulonephritis (GN)                  22,749     7.0    57     60.6  68.4   23.0    5.7    1.3     10.0    13.6 
. Other proliferative GN                      884     0.3    52     56.8  74.0   18.7    5.4    1.1     13.6    13.1 
Secondary GN/Vasculitis                     8,122     2.5    45     32.9  63.3   30.6    3.4    1.2      7.4    17.3 
. Lupus erythematosus, (SLE nephritis)      4,177     1.3    37     19.4  47.9   44.0    4.8    1.1      8.8    11.2 
. Polyarteritis                               173     0.1    64     49.1  82.1   11.6    4.6    1.2      5.8    23.7 
. Wegeners granulomatosis                     890     0.3    64     60.0  91.6    5.4    1.1    1.3      4.6    23.6 
. Henoch-Schonlein syndrome                   153     0.0    25     56.2  81.7    7.2    6.5    3.3     27.5     7.8 
. Vasculitis and its derivatives              467     0.1    68     48.4  88.2    8.1    1.3    1.3      2.6    26.8 
. Scleroderma                                 740     0.2    57     23.4  80.1   17.4    1.1    1.1      2.3    33.9 
. Hemolytic uremic syndrome                   695     0.2    49     36.5  82.4   15.3    1.3    0.7      7.9    19.6 
. Nephropathy from heroin /related abuse      661     0.2    58     62.3  58.7   35.4    2.7    2.0      7.3    20.0 
. Secondary GN, other                         166     0.1    49     55.4  58.4   34.9    1.8    2.4      3.6    21.1 
Interstitial Nephritis/Pyelonephritis      14,577     4.5    64     56.7  79.2   15.9    2.8    1.0      8.1    20.4 
. Chronic pyelonephritis, reflux neph.      1,805     0.6    52     38.0  84.2    9.9    3.5    1.1     13.5    13.1 
. Analgesic abuse                             416     0.1    65     35.3  77.4   18.0    2.4    0.7      2.4    17.5 
. Nephropathy caused by other agents        1,865     0.6    66     70.6  77.3   18.8    2.1    0.8      6.0    26.0 
. Nephrolithiasis, Obstruction, Gouty       4,078     1.3    67     72.7  78.6   16.3    3.0    0.8      7.0    23.2 
. Nephrocalcinosis                            121     0.0    67     51.2  77.7   14.0    4.1    0.8      4.1    23.1 
. Chronic interstitial nephritis            5,946     1.8    64     49.0  78.6   16.5    2.7    1.2      8.6    18.4 
. Acute interstitial nephritis                346     0.1    67     49.4  81.5   15.3    2.0    0.3      2.9    32.1 
Hypertensive/large vessel disease          93,651    29.0    69     57.2  58.2   37.5    2.6    0.8      2.1    24.2 
. Hypertension, (no primary ren. dis.)     86,403    26.7    68     56.9  55.4   40.2    2.7    0.8      2.2    23.2 
. Renal artery stenosis or occlusion        5,894     1.8    72     59.4  92.0    5.9    1.2    0.6      0.7    36.0 
. Cholesterol emboli, renal emboli          1,354     0.4    72     66.3  94.0    3.6    1.3    0.6      0.1    36.0 
Cystic/Heriditary/Congenital Diseases      11,618     3.6    51     55.9  82.2   13.3    2.3    0.8     19.6     6.5 
. Polycystic kidneys, adult (dominant)      8,724     2.7    54     52.3  83.2   12.6    2.4    0.7     16.6     6.5 
. Polycystic, infantile (recessive)            65     0.0    22     50.8  75.4   21.5    3.1    0.0      9.2    13.8 
. Medullary cystic, inc nephronophthisis       90     0.0    25     58.9  83.3   13.3    1.1    1.1     25.6     4.4 
. Alports, other hereditary/familial dis      720     0.2    31     72.1  84.4   10.6    1.8    1.4     29.2     2.6 
. Tuberous sclerosis                          139     0.0    62     43.9  80.6   15.1    2.2    1.4      5.8    23.7 
. Cystinosis                                   57     0.0    14     59.6  91.2    7.0    0.0    1.8     45.6     3.5 
. Primary oxalosis                             92     0.0    56     55.4  91.3    6.5    1.1    0.0     17.4    12.0 
. Fabrys disease                               79     0.0    42     92.4  88.6    7.6    0.0    2.5     21.5     5.1 
. Congenital nephrotic syndrome                84     0.0    21     44.0  63.1   25.0    9.5    1.2     16.7     7.1 
. Drash syndrome, mesangial sclerosis          11     0.0    44     54.5  54.5   36.4    0.0    9.1      9.1     0.0 
. Congenital obstructive uropathy             769     0.2    26     75.2  75.0   17.3    2.9    0.9     28.7     8.8 
. Renal hypoplasia, dysplasia                 734     0.2    15     58.9  75.7   18.7    1.5    1.5     36.2     4.5 
. Prune belly syndrome                         54     0.0    12    100.0  75.9   20.4    1.9    0.0     38.9     1.9 
Neoplasms/Tumors                            5,428     1.7    68     61.8  79.0   18.0    1.5    0.9      0.8    43.6 
. Renal or Urological Neoplasms             1,457     0.5    68     70.7  80.6   16.5    1.2    1.0      1.2    36.3 
. Multiple myeloma                          2,809     0.9    69     59.7  76.5   20.4    1.6    0.9      0.2    49.6 
. Light chain nephropathy                     158     0.0    71     59.5  75.9   18.4    3.2    0.6      1.3    39.2 
. Amyloidosis                               1,004     0.3    66     55.4  83.8   13.4    1.5    0.8      1.8    37.9 
Miscellaneous Conditions                    8,765     2.7    50     66.5  52.2   44.3    1.0    0.8      2.6    35.4 
. Complication post bone marr/other txp       111     0.0    53     61.3  84.7   11.7    0.9    1.8     10.8    18.0 
. Sickle cell disease/anemia or trait         345     0.1    39     52.2   5.2   92.2    0.0    1.4      1.7    16.5 
. AIDS nephropathy                          3,264     1.0    38     76.9   9.3   87.7    0.2    0.5      0.1    43.2 
. Traumatic/surgical loss of kidney(s)        175     0.1    64     69.1  82.3   12.6    1.7    1.1      2.9    19.4 
. Hepatorenal syndrome                        329     0.1    56     68.1  85.4    9.1    0.9    2.7     13.4    42.6 
. Tubular necrosis (no recovery)            3,188     1.0    68     60.0  84.2   12.9    1.3    0.7      2.4    33.2 
. Post-Partum Fail, Oth Renal Disorders     1,353     0.4    66     60.2  78.0   16.8    2.6    1.2      5.9    28.5 
Etiology Uncertain                         14,151     4.4    65     57.4  70.6   23.2    3.6    1.2      7.2    23.6 
Missing                                     9,175       .    66     50.7  46.6   23.4    1.3    0.6     14.6    36.8 

* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.

Table A.16
Incidence Of Reported ESRD Therapy By Detailed Primary Disease And Race
For All Patients, 1992-1996
                                                                                #                         Native
                                           Total          #       #       #  Native  White  Black  Asian  Amer.
Primary Disease Groups                    Patients    White   Black   Asian  Amer.    (%)    (%)    (%)    (%)

All ESRD, (reference)                     332,459   212,461  97,753  10,324  5,044   100.0  100.0  100.0  100.0 
Diabetes                                  130,473    83,729  37,185   4,298  3,188    40.2   38.9   42.1   63.9 
. Type 1, juvenile type                    46,100    32,377  11,469   1,086    734    15.6   12.0   10.6   14.7 
. Type 2, adult-onset or unspec. type      84,373    51,352  25,716   3,212  2,454    24.7   26.9   31.5   49.2 
Glomerulonephritis                         36,499    24,826   8,789   1,836    452    11.9    9.2   18.0    9.1 
. Focal glomerulosclerosis, focal GN        6,497     3,747   2,430     173     62     1.8    2.5    1.7    1.2 
. Membranous nephropathy                    1,554     1,109     376      36     17     0.5    0.4    0.4    0.3 
. Membranoproliferative GN, types 1&2       1,284       953     215      71     22     0.5    0.2    0.7    0.4 
. IgA nephropathy, Bergers disease          1,080       799      92     134     20     0.4    0.1    1.3    0.4 
. IgM nephropathy                             121        86      13      16      *     0.0    0.0    0.2    0.0 
. Rapidly progressive GN                    1,336     1,071     172      53     20     0.5    0.2    0.5    0.4 
. Goodpastures Syndrome                       780       697      55      14      *     0.3    0.1    0.1    0.2 
. Post infectious GN, SBE                     214       161      41       *      *     0.1    0.0    0.0    0.1 
. Glomerulonephritis (GN)                  22,749    15,549   5,230   1,286    287     7.5    5.5   12.6    5.7 
. Other proliferative GN                      884       654     165      48     10     0.3    0.2    0.5    0.2 
Secondary GN/Vasculitis                     8,122     5,144   2,482     274    101     2.5    2.6    2.7    2.0 
. Lupus erythematosus, (SLE nephritis)      4,177     1,999   1,838     202     46     1.0    1.9    2.0    0.9 
. Polyarteritis                               173       142      20       *      *     0.1    0.0    0.1    0.0 
. Wegeners granulomatosis                     890       815      48      10     12     0.4    0.1    0.1    0.2 
. Henoch-Schonlein syndrome                   153       125      11      10      *     0.1    0.0    0.1    0.1 
. Vasculitis and its derivatives              467       412      38       *      *     0.2    0.0    0.1    0.1 
. Scleroderma                                 740       593     129       *      *     0.3    0.1    0.1    0.2 
. Hemolytic uremic syndrome                   695       573     106       *      *     0.3    0.1    0.1    0.1 
. Nephropathy from heroin /related abuse      661       388     234      18     13     0.2    0.2    0.2    0.3 
. Secondary GN, other                         166        97      58       *      *     0.0    0.1    0.0    0.1 
Interstitial Nephritis/Pyelonephritis      14,577    11,541   2,321     410    139     5.5    2.4    4.0    2.8 
. Chronic pyelonephritis, reflux neph.      1,805     1,520     179      63     19     0.7    0.2    0.6    0.4 
. Analgesic abuse                             416       322      75      10      *     0.2    0.1    0.1    0.1 
. Nephropathy caused by other agents        1,865     1,442     350      40     15     0.7    0.4    0.4    0.3 
. Nephrolithiasis, Obstruction, Gouty       4,078     3,206     664     124     31     1.5    0.7    1.2    0.6 
. Nephrocalcinosis                            121        94      17       *      *     0.0    0.0    0.0    0.0 
. Chronic interstitial nephritis            5,946     4,675     983     161     69     2.2    1.0    1.6    1.4 
. Acute interstitial nephritis                346       282      53       *      *     0.1    0.1    0.1    0.0 
Hypertensive/large vessel disease          93,651    54,542  35,137   2,436    728    26.2   36.8   23.9   14.6 
. Hypertension, (no primary ren. dis.)     86,403    47,847  34,740   2,348    684    23.0   36.3   23.0   13.7 
. Renal artery stenosis or occlusion        5,894     5,422     348      70     36     2.6    0.4    0.7    0.7 
. Cholesterol emboli, renal emboli          1,354     1,273      49      18      *     0.6    0.1    0.2    0.2 
Cystic/Heriditary/Congenital Diseases      11,618     9,545   1,548     268     96     4.6    1.6    2.6    1.9 
. Polycystic kidneys, adult (dominant)      8,724     7,262   1,103     206     60     3.5    1.2    2.0    1.2 
. Polycystic, infantile (recessive)            65        49      14       *      0     0.0    0.0    0.0    0.0 
. Medullary cystic, inc nephronophthisis       90        75      12       *      *     0.0    0.0    0.0    0.0 
. Alports, other hereditary/familial dis      720       608      76      13     10     0.3    0.1    0.1    0.2 
. Tuberous sclerosis                          139       112      21       *      *     0.1    0.0    0.0    0.0 
. Cystinosis                                   57        52       *       0      *     0.0    0.0    0.0    0.0 
. Primary oxalosis                             92        84       *       *      0     0.0    0.0    0.0    0.0 
. Fabrys disease                               79        70       *       0      *     0.0    0.0    0.0    0.0 
. Congenital nephrotic syndrome                84        53      21       *      *     0.0    0.0    0.1    0.0 
. Drash syndrome, mesangial sclerosis          11         *       *       0      *     0.0    0.0    0.0    0.0 
. Congenital obstructive uropathy             769       577     133      22      *     0.3    0.1    0.2    0.1 
. Renal hypoplasia, dysplasia                 734       556     137      11     11     0.3    0.1    0.1    0.2 
. Prune belly syndrome                         54        41      11       *      0     0.0    0.0    0.0    0.0 
Neoplasms/Tumors                            5,428     4,286     976      84     48     2.1    1.0    0.8    1.0 
. Renal or Urological Neoplasms             1,457     1,175     240      18     15     0.6    0.3    0.2    0.3 
. Multiple myeloma                          2,809     2,150     572      46     24     1.0    0.6    0.5    0.5 
. Light chain nephropathy                     158       120      29       *      *     0.1    0.0    0.0    0.0 
. Amyloidosis                               1,004       841     135      15      *     0.4    0.1    0.1    0.2 
Miscellaneous Conditions                    8,765     4,579   3,881      92     74     2.2    4.1    0.9    1.5 
. Complication post bone marr/other txp       111        94      13       *      *     0.0    0.0    0.0    0.0 
. Sickle cell disease/anemia or trait         345        18     318       0      *     0.0    0.3    0.0    0.1 
. AIDS nephropathy                          3,264       302   2,861       *     17     0.1    3.0    0.1    0.3 
. Traumatic/surgical loss of kidney(s)        175       144      22       *      *     0.1    0.0    0.0    0.0 
. Hepatorenal syndrome                        329       281      30       *      *     0.1    0.0    0.0    0.2 
. Tubular necrosis (no recovery)            3,188     2,684     410      43     23     1.3    0.4    0.4    0.5 
. Post-Partum Fail, Oth Renal Disorders     1,353     1,056     227      35     16     0.5    0.2    0.3    0.3 
Etiology Uncertain                         14,151     9,994   3,286     506    166     4.8    3.4    5.0    3.3 
Missing                                     9,175     4,275   2,148     120     52       .      .      .      . 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.



Table A.17:  Incidence Of Reported ESRD Therapy
Median Age At Incidence, Sex, Race, and One Year Transplant and Death Status
By Detailed Primary Disease, For Patients Age 65 And Over, 1992-1996
                                                                                                 %    % Tran  % Died
                                           Total      %    Median    %      %      %      %    Native  First   First
Primary Disease Groups                    Patients  Incid   Age    Males  White  Black  Asian  Amer.    Year    Year

All ESRD, (reference)                     155,530   100.0    73     50.8   71.9  22.0    3.0    1.1      0.3    32.4 
Diabetes                                   55,794    37.1    71     42.8   67.3  25.7    3.8    1.9      0.2    30.1 
. Type 1, juvenile type                    14,571     9.7    71     42.3   71.0  23.8    3.1    1.2      0.2    31.6 
. Type 2, adult-onset or unspec. type      41,223    27.4    71     42.9   66.0  26.4    4.1    2.1      0.2    29.6 
Glomerulonephritis                         12,277     8.2    73     59.4   83.7  11.2    3.7    0.8      0.9    25.6 
. Focal glomerulosclerosis, focal GN        1,396     0.9    72     65.1   84.0  12.5    2.5    0.6      1.4    20.6 
. Membranous nephropathy                      533     0.4    72     63.4   81.8  13.9    3.0    0.6      1.1    18.8 
. Membranoproliferative GN, types 1&2         264     0.2    72     58.7   87.5   9.5    1.5    1.1      1.1    19.7 
. IgA nephropathy, Bergers disease            148     0.1    71     72.3   88.5   3.4    7.4    0.0      0.0    21.6 
. IgM nephropathy                              18     0.0    71     83.3   88.9   5.6    5.6    0.0      5.6     5.6 
. Rapidly progressive GN                      577     0.4    73     50.6   89.9   6.9    1.6    0.9      0.3    30.5 
. Goodpastures Syndrome                       376     0.2    73     45.2   93.6   4.5    0.8    0.5      0.3    35.9 
. Post infectious GN, SBE                      70     0.0    74     62.9   91.4   7.1    1.4    0.0      0.0    27.1 
. Glomerulonephritis (GN)                   8,626     5.7    74     59.3   82.5  11.7    4.3    0.9      0.9    26.2 
. Other proliferative GN                      269     0.2    72     55.4   87.7   9.3    2.2    0.7      0.0    27.9 
Secondary GN/Vasculitis                     1,860     1.2    72     44.0   87.1  10.2    1.5    0.8      0.4    35.6 
. Lupus erythematosus, (SLE nephritis)        355     0.2    70     25.4   71.0  25.1    2.3    0.3      0.3    32.7 
. Polyarteritis                                79     0.1    74     40.5   88.6   8.9    1.3    1.3      1.3    29.1 
. Wegeners granulomatosis                     432     0.3    72     55.8   95.8   2.1    1.2    0.9      0.2    35.6 
. Henoch-Schonlein syndrome                    14     0.0    73     71.4   92.9   0.0    7.1    0.0      0.0    42.9 
. Vasculitis and its derivatives              275     0.2    74     52.4   94.5   3.3    1.1    1.1      0.4    33.8 
. Scleroderma                                 219     0.1    70     23.3   92.7   5.9    0.9    0.5      0.5    48.4 
. Hemolytic uremic syndrome                   172     0.1    72     34.9   90.1   8.7    0.0    0.6      0.0    39.5 
. Nephropathy from heroin /related abuse      264     0.2    74     61.7   79.5  16.3    1.9    1.5      0.4    30.3 
. Secondary GN, other                          50     0.0    73     54.0   86.0   8.0    6.0    0.0      2.0    34.0 
Interstitial Nephritis/Pyelonephritis       7,220     4.8    74     60.0   83.7  12.6    2.4    0.7      0.6    30.7 
. Chronic pyelonephritis, reflux neph.        573     0.4    74     36.6   86.4   9.1    3.5    0.7      0.9    30.2 
. Analgesic abuse                             221     0.1    73     38.5   83.3  12.2    2.7    0.5      0.5    24.0 
. Nephropathy caused by other agents        1,018     0.7    74     74.5   80.4  16.1    2.2    0.8      0.4    35.5 
. Nephrolithiasis, Obstruction, Gouty       2,294     1.5    75     76.9   82.3  13.9    2.3    0.7      0.3    33.6 
. Nephrocalcinosis                             64     0.0    76     53.1   79.7  14.1    4.7    0.0      1.6    35.9 
. Chronic interstitial nephritis            2,850     1.9    74     48.2   85.4  11.3    2.4    0.7      0.9    26.3 
. Acute interstitial nephritis                200     0.1    74     52.0   86.5  10.0    2.5    0.5      0.0    44.0 
Hypertensive/large vessel disease          57,302    38.1    74     54.4   71.3  25.1    2.5    0.6      0.2    33.4 
. Hypertension, (no primary ren. dis.)     51,365    34.1    75     53.7   68.8  27.5    2.6    0.6      0.2    32.8 
. Renal artery stenosis or occlusion        4,814     3.2    74     59.8   93.2   5.0    1.2    0.4      0.1    39.0 
. Cholesterol emboli, renal emboli          1,123     0.7    74     65.7   94.9   2.9    1.2    0.4      0.1    39.1 
Cystic/Heriditary/Congenital Diseases       2,595     1.7    72     52.0   85.1  11.3    2.4    0.6      1.7    17.3 
. Polycystic kidneys, adult (dominant)      2,244     1.5    71     50.6   85.3  11.1    2.5    0.5      1.8    15.6 
. Polycystic, infantile (recessive)             *     0.0    73     50.0   66.7  33.3    0.0    0.0      0.0    16.7 
. Medullary cystic, inc nephronophthisis       13     0.0    73     69.2   76.9  15.4    7.7    0.0      0.0    30.8 
. Alports, other hereditary/familial dis       48     0.0    70     43.8   97.9   2.1    0.0    0.0      4.2    12.5 
. Tuberous sclerosis                           63     0.0    74     55.6   90.5   7.9    0.0    1.6      0.0    38.1 
. Cystinosis                                    *     0.0    76      0.0  100.0   0.0    0.0    0.0      0.0     0.0 
. Primary oxalosis                             29     0.0    70     48.3   89.7  10.3    0.0    0.0      0.0    20.7 
. Fabrys disease                                *     0.0    71     50.0   50.0  50.0    0.0    0.0      0.0     0.0 
. Congenital nephrotic syndrome                10     0.0    76     50.0   80.0  10.0   10.0    0.0      0.0    30.0 
. Drash syndrome, mesangial sclerosis           *     0.0    68     75.0   75.0  25.0    0.0    0.0      0.0     0.0 
. Congenital obstructive uropathy             130     0.1    74     74.6   76.2  16.2    3.8    0.8      0.0    32.3 
. Renal hypoplasia, dysplasia                  43     0.0    73     53.5   81.4  16.3    0.0    2.3      0.0    25.6 
. Prune belly syndrome                          *     0.0    80    100.0  100.0   0.0    0.0    0.0      0.0    50.0 
Neoplasms/Tumors                            3,341     2.2    73     62.2   82.4  15.3    1.3    0.6      0.0    50.9 
. Renal or Urological Neoplasms               877     0.6    74     73.8   83.9  13.6    1.1    1.0      0.1    43.8 
. Multiple myeloma                          1,819     1.2    73     59.4   80.4  17.3    1.3    0.5      0.0    55.5 
. Light chain nephropathy                     100     0.1    76     61.0   82.0  15.0    3.0    0.0      0.0    47.0 
. Amyloidosis                                 545     0.4    72     53.0   86.4  11.4    1.5    0.4      0.0    47.3 
Miscellaneous Conditions                    2,836     1.9    74     60.4   88.2   9.1    1.6    0.7      0.4    41.9 
. Complication post bone marr/other txp        20     0.0    67     55.0   95.0   0.0    0.0    5.0     10.0    20.0 
. Sickle cell disease/anemia or trait          18     0.0    72     38.9   22.2  77.8    0.0    0.0      0.0    50.0 
. AIDS nephropathy                             35     0.0    71     65.7   40.0  54.3    2.9    0.0      0.0    40.0 
. Traumatic/surgical loss of kidney(s)         86     0.1    74     66.3   87.2   8.1    2.3    1.2      0.0    33.7 
. Hepatorenal syndrome                         83     0.1    70     68.7   85.5   6.0    0.0    7.2      3.6    63.9 
. Tubular necrosis (no recovery)            1,880     1.2    74     57.7   90.4   7.6    1.3    0.4      0.1    41.8 
. Post-Partum Fail, Oth Renal Disorders       714     0.5    75     66.4   86.4   9.7    2.5    0.7      0.4    40.9 
Etiology Uncertain                          7,250     4.8    75     55.8   80.2  15.3    3.1    0.8      0.3    36.3 
Missing                                     5,055       .    73     47.0   42.8  15.1    0.9    0.5      1.5    49.5 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.

 
Table A.18:  Incidence Of Reported ESRD Therapy
By Detailed Primary Disease And Race
For Patients Age 65 And Over, 1992-1996
                                                                                    #                             Native
                                            Total           #        #     #     Native   White   Black   Asian   Amer.
Primary Disease Groups                     Patients     White    Black   Asian   Amer.     (%)     (%)     (%)     (%)
All ESRD, (reference)                      155,530    111,817   34,143   4,625   1,699    100.0   100.0   100.0   100.0 
Diabetes                                    55,794     37,568   14,360   2,137   1,040     34.3    43.0    46.6    62.1 
. Type 1, juvenile type                     14,571     10,346    3,475     458     182      9.4    10.4    10.0    10.9 
. Type 2, adult-onset or unspec. type       41,223     27,222   10,885   1,679     858     24.8    32.6    36.7    51.2 
Glomerulonephritis                          12,277     10,270    1,379     453     102      9.4     4.1     9.9     6.1 
. Focal glomerulosclerosis, focal GN         1,396      1,172      174      35       *      1.1     0.5     0.8     0.5 
. Membranous nephropathy                       533        436       74      16       *      0.4     0.2     0.3     0.2 
. Membranoproliferative GN, types 1&2          264        231       25       *       *      0.2     0.1     0.1     0.2 
. IgA nephropathy, Bergers disease             148        131        *      11       0      0.1     0.0     0.2     0.0 
. IgM nephropathy                               18         16        *       *       0      0.0     0.0     0.0     0.0 
. Rapidly progressive GN                       577        519       40       *       *      0.5     0.1     0.2     0.3 
. Goodpastures Syndrome                        376        352       17       *       *      0.3     0.1     0.1     0.1 
. Post infectious GN, SBE                       70         64        *       *       0      0.1     0.0     0.0     0.0 
. Glomerulonephritis (GN)                    8,626      7,113    1,013     367      79      6.5     3.0     8.0     4.7 
. Other proliferative GN                       269        236       25       *       *      0.2     0.1     0.1     0.1 
Secondary GN/Vasculitis                      1,860      1,620      189      28      15      1.5     0.6     0.6     0.9 
. Lupus erythematosus, (SLE nephritis)         355        252       89       *       *      0.2     0.3     0.2     0.1 
. Polyarteritis                                 79         70        *       *       *      0.1     0.0     0.0     0.1 
. Wegeners granulomatosis                      432        414        *       *       *      0.4     0.0     0.1     0.2 
. Henoch-Schonlein syndrome                     14         13        0       *       0      0.0     0.0     0.0     0.0 
. Vasculitis and its derivatives               275        260        *       *       *      0.2     0.0     0.1     0.2 
. Scleroderma                                  219        203       13       *       *      0.2     0.0     0.0     0.1 
. Hemolytic uremic syndrome                    172        155       15       0       *      0.1     0.0     0.0     0.1 
. Nephropathy from heroin /related abuse       264        210       43       *       *      0.2     0.1     0.1     0.2 
. Secondary GN, other                           50         43        *       *       0      0.0     0.0     0.1     0.0 
Interstitial Nephritis/Pyelonephritis        7,220      6,042      912     175      48      5.5     2.7     3.8     2.9 
. Chronic pyelonephritis, reflux neph.         573        495       52      20       *      0.5     0.2     0.4     0.2 
. Analgesic abuse                              221        184       27       *       *      0.2     0.1     0.1     0.1 
. Nephropathy caused by other agents         1,018        818      164      22       *      0.7     0.5     0.5     0.5 
. Nephrolithiasis, Obstruction, Gouty        2,294      1,888      319      52      15      1.7     1.0     1.1     0.9 
. Nephrocalcinosis                              64         51        *       *       0      0.0     0.0     0.1     0.0 
. Chronic interstitial nephritis             2,850      2,433      321      67      19      2.2     1.0     1.5     1.1 
. Acute interstitial nephritis                 200        173       20       *       *      0.2     0.1     0.1     0.1 
Hypertensive/large vessel disease           57,302     40,876   14,377   1,409     353     37.3    43.1    30.8    21.1 
. Hypertension, (no primary ren. dis.)      51,365     35,322   14,104   1,338     328     32.2    42.3    29.2    19.6 
. Renal artery stenosis or occlusion         4,814      4,488      240      57      20      4.1     0.7     1.2     1.2 
. Cholesterol emboli, renal emboli           1,123      1,066       33      14       *      1.0     0.1     0.3     0.3 
Cystic/Heriditary/Congenital Diseases        2,595      2,208      292      62      15      2.0     0.9     1.4     0.9 
. Polycystic kidneys, adult (dominant)       2,244      1,915      248      55      12      1.7     0.7     1.2     0.7 
. Polycystic, infantile (recessive)              *          *        *       0       0      0.0     0.0     0.0     0.0 
. Medullary cystic, inc nephronophthisis        13         10        *       *       0      0.0     0.0     0.0     0.0 
. Alports, other hereditary/familial dis        48         47        *       0       0      0.0     0.0     0.0     0.0 
. Tuberous sclerosis                            63         57        *       0       *      0.1     0.0     0.0     0.1 
. Cystinosis                                     *          *        0       0       0      0.0     0.0     0.0     0.0 
. Primary oxalosis                              29         26        *       0       0      0.0     0.0     0.0     0.0 
. Fabrys disease                                 *          *        *       0       0      0.0     0.0     0.0     0.0 
. Congenital nephrotic syndrome                 10          *        *       *       0      0.0     0.0     0.0     0.0 
. Drash syndrome, mesangial sclerosis            *          *        *       0       0      0.0     0.0     0.0     0.0 
. Congenital obstructive uropathy              130         99       21       *       *      0.1     0.1     0.1     0.1 
. Renal hypoplasia, dysplasia                   43         35        *       0       *      0.0     0.0     0.0     0.1 
. Prune belly syndrome                           *          *        0       0       0      0.0     0.0     0.0     0.0 
Neoplasms/Tumors                             3,341      2,752      510      45      21      2.5     1.5     1.0     1.3 
. Renal or Urological Neoplasms                877        736      119      10       *      0.7     0.4     0.2     0.5 
. Multiple myeloma                           1,819      1,463      314      24      10      1.3     0.9     0.5     0.6 
. Light chain nephropathy                      100         82       15       *       0      0.1     0.0     0.1     0.0 
. Amyloidosis                                  545        471       62       *       *      0.4     0.2     0.2     0.1 
Miscellaneous Conditions                     2,836      2,500      257      46      20      2.3     0.8     1.0     1.2 
. Complication post bone marr/other txp         20         19        0       0       *      0.0     0.0     0.0     0.1 
. Sickle cell disease/anemia or trait           18          *       14       0       0      0.0     0.0     0.0     0.0 
. AIDS nephropathy                              35         14       19       *       0      0.0     0.1     0.0     0.0 
. Traumatic/surgical loss of kidney(s)          86         75        *       *       *      0.1     0.0     0.0     0.1 
. Hepatorenal syndrome                          83         71        *       0       *      0.1     0.0     0.0     0.4 
. Tubular necrosis (no recovery)             1,880      1,700      143      25       *      1.6     0.4     0.5     0.4 
. Post-Partum Fail, Oth Renal Disorders        714        617       69      18       *      0.6     0.2     0.4     0.3 
Etiology Uncertain                           7,250      5,815    1,106     226      61      5.3     3.3     4.9     3.6 
Missing                                      5,055      2,166      761      44      24        .       .       .       . 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.

 

Table A.19:  Incidence Of Reported ESRD Therapy
Median Age At Incidence, Sex, Race, and One Year Transplant and Death Status
By Detailed Primary Disease, For Adult Patients Age 20-64, 1992-1996

                                                                                                  %    % Tran  % Died
                                           Total      %    Median    %      %      %      %    Native  First   First
Primary Disease Groups                    Patients  Incid   Age    Males  White  Black  Asian  Amer.    Year    Year

All ESRD, (reference)                     171,774   100.0    51     55.3  56.7   36.2    3.2     1.9     8.7    12.1 
Diabetes                                   74,596    44.4    54     50.8  61.8   30.6    2.9     2.9     6.2    13.6 
. Type 1, juvenile type                    31,487    18.7    49     52.6  69.9   25.3    2.0     1.8    10.5    13.5 
. Type 2, adult-onset or unspec. Type      43,109    25.7    56     49.5  55.9   34.4    3.6     3.7     3.0    13.6 
Glomerulonephritis                         22,587    13.4    44     62.0  60.3   30.4    5.8     1.4    15.3     5.8 
. Focal glomerulosclerosis, focal GN        4,586     2.7    41     62.3  51.2   43.9    2.6     1.1    15.7     5.3 
. Membranous nephropathy                      998     0.6    49     68.5  66.5   28.9    2.0     1.4    16.0     5.2 
. Membranoproliferative GN, types 1&2         890     0.5    42     63.1  71.1   18.1    7.0     1.9    20.1     5.5 
. IgA nephropathy, Bergers disease            866     0.5    39     69.1  71.8    9.1   13.9     1.7    21.5     2.0 
. IgM nephropathy                              97     0.1    39     64.9  69.1    9.3   15.5     1.0    32.0     3.1 
. Rapidly progressive GN                      653     0.4    47     55.3  73.2   18.4    5.4     1.4    12.7     4.6 
. Goodpastures Syndrome                       370     0.2    49     49.2  85.1    9.5    2.7     1.9    10.8    14.9 
. Post infectious GN, SBE                     137     0.1    44     62.0  67.2   24.8    2.9     2.9    11.7     7.3 
. Glomerulonephritis (GN)                  13,440     8.0    44     61.7  59.8   29.8    6.5     1.5    14.6     6.1 
. Other proliferative GN                      550     0.3    44     57.8  68.2   22.4    6.9     1.5    17.8     7.1 
Secondary GN/Vasculitis                     5,792     3.4    41     29.1  55.8   37.4    3.7     1.4     8.5    12.4 
. Lupus erythematosus, (SLE nephritis)      3,565     2.1    37     18.5  45.7   46.2    4.8     1.2     9.6     9.3 
. Polyarteritis                                87     0.1    47     60.9  78.2   13.8    5.7     1.1     6.9    18.4 
. Wegeners granulomatosis                     430     0.3    54     64.9  87.7    8.6    1.2     1.9     8.1    12.6 
. Henoch-Schonlein syndrome                    89     0.1    32     56.2  75.3   12.4    7.9     4.5    23.6     5.6 
. Vasculitis and its derivatives              185     0.1    53     42.7  80.5   13.5    1.6     1.6     5.4    17.3 
. Scleroderma                                 520     0.3    50     23.5  75.0   22.1    1.2     1.3     3.1    27.9 
. Hemolytic uremic syndrome                   424     0.3    45     32.3  79.0   19.3    1.2     0.5     5.0    15.3 
. Nephropathy from heroin /related abuse      380     0.2    44     63.4  44.5   49.2    2.6     2.4    10.3    13.7 
. Secondary GN, other                         112     0.1    43     57.1  44.6   48.2    0.0     3.6     3.6    16.1 
Interstitial Nephritis/Pyelonephritis       6,799     4.0    48     52.7  74.6   19.3    3.2     1.3    12.9    10.9 
. Chronic pyelonephritis, reflux neph.      1,112     0.7    42     38.0  83.5   10.1    3.6     1.3    17.8     5.6 
. Analgesic abuse                             193     0.1    53     31.6  70.5   24.9    2.1     1.0     4.7    10.4 
. Nephropathy caused by other agents          776     0.5    51     65.7  72.9   22.7    2.3     0.8     9.8    15.7 
. Nephrolithiasis, Obstruction, Gouty       1,553     0.9    51     65.9  73.7   19.2    4.3     1.0    10.5    11.1 
. Nephrocalcinosis                             56     0.0    51     50.0  75.0   14.3    3.6     1.8     7.1     8.9 
. Chronic interstitial nephritis            2,973     1.8    48     49.6  72.4   21.6    2.9     1.6    14.2    11.3 
. Acute interstitial nephritis                136     0.1    53     44.1  76.5   20.6    1.5     0.0     5.1    16.9 
Hypertensive/large vessel disease          36,091    21.5    51     61.5  37.6   57.1    2.8     1.0     4.9     9.7 
. Hypertension, (no primary ren. dis.)     34,801    20.7    51     61.6  35.8   58.9    2.9     1.0     5.0     9.2 
. Renal artery stenosis or occlusion        1,059     0.6    60     58.1  86.7    9.9    1.2     1.4     3.1    23.3 
. Cholesterol emboli, renal emboli            231     0.1    61     69.3  89.6    6.9    1.7     1.3     0.4    20.8 
Cystic/Heriditary/Congenital Diseases       7,764     4.6    48     55.4  82.7   13.1    2.2     0.8    21.7     3.5 
. Polycystic kidneys, adult (dominant)      6,352     3.8    50     53.0  82.6   13.2    2.3     0.7    21.2     3.3 
. Polycystic, infantile (recessive)            28     0.0    43     60.7  78.6   21.4    0.0     0.0    14.3    17.9 
. Medullary cystic, inc nephronophthisis       37     0.0    33     59.5  83.8   13.5    0.0     0.0    24.3     0.0 
. Alports, other hereditary/familial dis      523     0.3    34     70.7  87.2    8.2    1.7     1.0    28.1     2.3 
. Tuberous sclerosis                           73     0.0    47     32.9  74.0   20.5    2.7     1.4     9.6    12.3 
. Cystinosis                                   17     0.0    43     58.8  88.2    5.9    0.0     5.9    11.8    11.8 
. Primary oxalosis                             50     0.0    53     58.0  94.0    4.0    0.0     0.0    20.0    10.0 
. Fabrys disease                               76     0.0    42     93.4  89.5    6.6    0.0     2.6    22.4     5.3 
. Congenital nephrotic syndrome                33     0.0    36     48.5  54.5   36.4    9.1     0.0    21.2     0.0 
. Drash syndrome, mesangial sclerosis           *     0.0    44     33.3   0.0   66.7    0.0    33.3     0.0     0.0 
. Congenital obstructive uropathy             343     0.2    35     70.6  79.3   15.7    2.6     1.2    21.3     5.5 
. Renal hypoplasia, dysplasia                 219     0.1    33     55.7  82.2   15.5    0.5     0.5    26.9     1.8 
. Prune belly syndrome                         10     0.0    26    100.0  80.0   20.0    0.0     0.0    10.0     0.0 
Neoplasms/Tumors                            2,055     1.2    56     61.5  73.6   22.3    1.8     1.2     1.8    32.1 
. Renal or Urological Neoplasms               549     0.3    56     66.8  76.3   20.8    1.3     0.7     2.2    25.3 
. Multiple myeloma                            990     0.6    57     60.2  69.4   26.1    2.2     1.4     0.6    38.7 
. Light chain nephropathy                      58     0.0    56     56.9  65.5   24.1    3.4     1.7     3.4    25.9 
. Amyloidosis                                 458     0.3    55     58.3  80.6   15.9    1.5     1.3     3.9    26.9 
Miscellaneous Conditions                    5,783     3.4    41     69.7  34.6   61.7    0.8     0.9     3.1    33.0 
. Complication post bone marr/other txp        90     0.1    50     62.2  82.2   14.4    1.1     1.1    10.0    17.8 
. Sickle cell disease/anemia or trait         312     0.2    39     52.2   4.2   92.9    0.0     1.6     1.3    15.4 
. AIDS nephropathy                          3,211     1.9    38     77.0   8.9   88.0    0.2     0.5     0.1    43.4 
. Traumatic/surgical loss of kidney(s)         84     0.1    45     73.8  78.6   16.7    1.2     1.2     6.0     6.0 
. Hepatorenal syndrome                        244     0.1    52     67.6  85.7    9.8    1.2     1.2    16.4    35.7 
. Tubular necrosis (no recovery)            1,258     0.7    53     63.8  75.4   20.3    1.4     1.3     5.0    21.4 
. Post-Partum Fail, Oth Renal Disorders       584     0.3    49     53.3  69.2   24.7    2.9     1.5     9.8    15.2 
Etiology Uncertain                          6,483     3.9    47     59.6  60.3   32.0    4.1     1.5    12.8    10.8 
Missing                                     3,824       .    50     54.9  50.6   34.1    1.9     0.7    27.8    22.6 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.

 
Table A.20:  Incidence Of Reported ESRD Therapy
By Detailed Primary Disease And Race
For Adult Patients Age 20-64, 1992-1996

                                                                                   #                             Native
                                            Total          #        #     #     Native   White   Black   Asian   Amer.
Primary Disease Groups                     Patients    White    Black   Asian   Amer.     (%)     (%)     (%)     (%)

All ESRD, (reference)                      171,774    97,394   62,196   5,495   3,266    100.0   100.0   100.0   100.0 
Diabetes                                    74,596    46,116   22,797   2,157   2,146     48.3    37.4    39.8    66.3 
. Type 1, juvenile type                     31,487    22,009    7,978     626     552     23.1    13.1    11.5    17.0 
. Type 2, adult-onset or unspec. type       43,109    24,107   14,819   1,531   1,594     25.3    24.3    28.2    49.2 
Glomerulonephritis                          22,587    13,625    6,873   1,299     320     14.3    11.3    23.9     9.9 
. Focal glomerulosclerosis, focal GN         4,586     2,346    2,014     120      49      2.5     3.3     2.2     1.5 
. Membranous nephropathy                       998       664      288      20      14      0.7     0.5     0.4     0.4 
. Membranoproliferative GN, types 1&2          890       633      161      62      17      0.7     0.3     1.1     0.5 
. IgA nephropathy, Bergers disease             866       622       79     120      15      0.7     0.1     2.2     0.5 
. IgM nephropathy                               97        67        *      15       *      0.1     0.0     0.3     0.0 
. Rapidly progressive GN                       653       478      120      35       *      0.5     0.2     0.6     0.3 
. Goodpastures Syndrome                        370       315       35      10       *      0.3     0.1     0.2     0.2 
. Post infectious GN, SBE                      137        92       34       *       *      0.1     0.1     0.1     0.1 
. Glomerulonephritis (GN)                   13,440     8,033    4,010     875     196      8.4     6.6    16.1     6.1 
. Other proliferative GN                       550       375      123      38       *      0.4     0.2     0.7     0.2 
Secondary GN/Vasculitis                      5,792     3,234    2,169     213      81      3.4     3.6     3.9     2.5 
. Lupus erythematosus, (SLE nephritis)       3,565     1,629    1,646     172      43      1.7     2.7     3.2     1.3 
. Polyarteritis                                 87        68       12       *       *      0.1     0.0     0.1     0.0 
. Wegeners granulomatosis                      430       377       37       *       *      0.4     0.1     0.1     0.2 
. Henoch-Schonlein syndrome                     89        67       11       *       *      0.1     0.0     0.1     0.1 
. Vasculitis and its derivatives               185       149       25       *       *      0.2     0.0     0.1     0.1 
. Scleroderma                                  520       390      115       *       *      0.4     0.2     0.1     0.2 
. Hemolytic uremic syndrome                    424       335       82       *       *      0.4     0.1     0.1     0.1 
. Nephropathy from heroin /related abuse       380       169      187      10       *      0.2     0.3     0.2     0.3 
. Secondary GN, other                          112        50       54       0       *      0.1     0.1     0.0     0.1 
Interstitial Nephritis/Pyelonephritis        6,799     5,074    1,312     219      87      5.3     2.2     4.0     2.7 
. Chronic pyelonephritis, reflux neph.       1,112       929      112      40      15      1.0     0.2     0.7     0.5 
. Analgesic abuse                              193       136       48       *       *      0.1     0.1     0.1     0.1 
. Nephropathy caused by other agents           776       566      176      18       *      0.6     0.3     0.3     0.2 
. Nephrolithiasis, Obstruction, Gouty        1,553     1,145      298      67      15      1.2     0.5     1.2     0.5 
. Nephrocalcinosis                              56        42        *       *       *      0.0     0.0     0.0     0.0 
. Chronic interstitial nephritis             2,973     2,152      642      86      48      2.3     1.1     1.6     1.5 
. Acute interstitial nephritis                 136       104       28       *       0      0.1     0.0     0.0     0.0 
Hypertensive/large vessel disease           36,091    13,567   20,624   1,019     368     14.2    33.9    18.8    11.4 
. Hypertension, (no primary ren. dis.)      34,801    12,442   20,503   1,002     350     13.0    33.7    18.5    10.8 
. Renal artery stenosis or occlusion         1,059       918      105      13      15      1.0     0.2     0.2     0.5 
. Cholesterol emboli, renal emboli             231       207       16       *       *      0.2     0.0     0.1     0.1 
Cystic/Heriditary/Congenital Diseases        7,764     6,420    1,017     168      61      6.7     1.7     3.1     1.9 
. Polycystic kidneys, adult (dominant)       6,352     5,249      836     144      46      5.5     1.4     2.7     1.4 
. Polycystic, infantile (recessive)             28        22        *       0       0      0.0     0.0     0.0     0.0 
. Medullary cystic, inc nephronophthisis        37        31        *       0       0      0.0     0.0     0.0     0.0 
. Alports, other hereditary/familial dis       523       456       43       *       *      0.5     0.1     0.2     0.2 
. Tuberous sclerosis                            73        54       15       *       *      0.1     0.0     0.0     0.0 
. Cystinosis                                    17        15        *       0       *      0.0     0.0     0.0     0.0 
. Primary oxalosis                              50        47        *       0       0      0.0     0.0     0.0     0.0 
. Fabrys disease                                76        68        *       0       *      0.1     0.0     0.0     0.1 
. Congenital nephrotic syndrome                 33        18       12       *       0      0.0     0.0     0.1     0.0 
. Drash syndrome, mesangial sclerosis            *         0        *       0       *      0.0     0.0     0.0     0.0 
. Congenital obstructive uropathy              343       272       54       *       *      0.3     0.1     0.2     0.1 
. Renal hypoplasia, dysplasia                  219       180       34       *       *      0.2     0.1     0.0     0.0 
. Prune belly syndrome                          10         *        *       0       0      0.0     0.0     0.0     0.0 
Neoplasms/Tumors                             2,055     1,513      459      38      25      1.6     0.8     0.7     0.8 
. Renal or Urological Neoplasms                549       419      114       *       *      0.4     0.2     0.1     0.1 
. Multiple myeloma                             990       687      258      22      14      0.7     0.4     0.4     0.4 
. Light chain nephropathy                       58        38       14       *       *      0.0     0.0     0.0     0.0 
. Amyloidosis                                  458       369       73       *       *      0.4     0.1     0.1     0.2 
Miscellaneous Conditions                     5,783     2,001    3,568      45      52      2.1     5.9     0.8     1.6 
. Complication post bone marr/other txp         90        74       13       *       *      0.1     0.0     0.0     0.0 
. Sickle cell disease/anemia or trait          312        13      290       0       *      0.0     0.5     0.0     0.2 
. AIDS nephropathy                           3,211       286    2,827       *      17      0.3     4.6     0.1     0.5 
. Traumatic/surgical loss of kidney(s)          84        66       14       *       *      0.1     0.0     0.0     0.0 
. Hepatorenal syndrome                         244       209       24       *       *      0.2     0.0     0.1     0.1 
. Tubular necrosis (no recovery)             1,258       949      256      17      16      1.0     0.4     0.3     0.5 
. Post-Partum Fail, Oth Renal Disorders        584       404      144      17       *      0.4     0.2     0.3     0.3 
Etiology Uncertain                           6,483     3,909    2,072     266      99      4.1     3.4     4.9     3.1 
Missing                                      3,824     1,935    1,305      71      27        .       .       .       . 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.


Table A.21:  Incidence Of Reported ESRD Therapy
Median Age At Incidence, Sex, Race, and One Year Transplant and Death Status
By Detailed Primary Disease, For Pediatric Patients Age < 20, 1992-1996

                                                                                                  %    % Tran  % Died
                                           Total      %    Median    %      %      %      %    Native  First   First
Primary Disease Groups                    Patients  Incid   Age    Males  White  Black  Asian  Amer.    Year    Year

All ESRD, (reference)                      5,155    100.0    14     57.1   63.0   27.4   4.0    1.5     37.3     2.9 
Diabetes                                      83      1.7    16     39.8   54.2   33.7   4.8    2.4     13.3     2.4 
. Type 1, juvenile type                       42      0.9    18     40.5   52.4   38.1   4.8    0.0     23.8     2.4 
. Type 2, adult-onset or unspec. type         41      0.8     3     39.0   56.1   29.3   4.9    4.9      2.4     2.4 
Glomerulonephritis                         1,635     33.6    16     55.0   56.9   32.8   5.1    1.8     33.3     1.6 
. Focal glomerulosclerosis, focal GN         515     10.6    16     60.2   44.5   47.0   3.5    1.0     30.9     1.2 
. Membranous nephropathy                      23      0.5    16     52.2   39.1   60.9   0.0    0.0     13.0     4.3 
. Membranoproliferative GN, types 1&2        130      2.7    15     45.4   68.5   22.3   3.8    1.5     36.9     0.0 
. IgA nephropathy, Bergers disease            66      1.4    17     71.2   69.7   12.1   4.5    7.6     28.8     0.0 
. IgM nephropathy                              *      0.1    19     33.3   50.0   50.0   0.0    0.0     33.3     0.0 
. Rapidly progressive GN                     106      2.2    14     39.6   69.8   11.3   8.5    5.7     33.0     0.9 
. Goodpastures Syndrome                       34      0.7    16     47.1   88.2    8.8   2.9    0.0     17.6     2.9 
. Post infectious GN, SBE                      *      0.1    15     42.9   71.4   28.6   0.0    0.0     28.6    14.3 
. Glomerulonephritis (GN)                    683     14.1    16     54.8   59.0   30.3   6.4    1.8     36.5     2.0 
. Other proliferative GN                      65      1.3    16     53.8   66.2   26.2   6.2    0.0     33.8     3.1 
Secondary GN/Vasculitis                      470      9.7    16     36.6   61.7   26.4   7.0    1.1     21.1     5.5 
. Lupus erythematosus, (SLE nephritis)       257      5.3    17     24.5   45.9   40.1   8.6    0.8     10.1     7.0 
. Polyarteritis                                *      0.1    14      0.0   57.1   14.3  28.6    0.0     42.9    28.6 
. Wegeners granulomatosis                     28      0.6    17     50.0   85.7    7.1   0.0    0.0     17.9     7.1 
. Henoch-Schonlein syndrome                   50      1.0    14     52.0   90.0    0.0   4.0    2.0     42.0     2.0 
. Vasculitis and its derivatives               *      0.1    18     42.9   42.9   57.1   0.0    0.0     14.3     0.0 
. Scleroderma                                  *      0.0    17      0.0    0.0  100.0   0.0    0.0      0.0     0.0 
. Hemolytic uremic syndrome                   99      2.0     9     57.6   83.8    9.1   4.0    2.0     34.3     3.0 
. Nephropathy from heroin /related abuse      17      0.3    13     47.1   52.9   23.5  17.6    0.0     47.1     0.0 
. Secondary GN, other                          *      0.1    12     25.0  100.0    0.0   0.0    0.0     25.0     0.0 
Interstitial Nephritis/Pyelonephritis        558     11.5    14     63.3   76.2   17.4   2.9    0.7     45.2     2.5 
. Chronic pyelonephritis, reflux neph.       120      2.5    16     44.2   80.0   12.5   2.5    0.0     33.3     0.8 
. Analgesic abuse                              *      0.0    18     50.0  100.0    0.0   0.0    0.0      0.0     0.0 
. Nephropathy caused by other agents          71      1.5    14     69.0   81.7   14.1   0.0    1.4     43.7     2.8 
. Nephrolithiasis, Obstruction, Gouty        231      4.8    12     76.2   74.9   20.3   2.2    0.4     49.8     2.2 
. Nephrocalcinosis                             *      0.0    15      0.0  100.0    0.0   0.0    0.0      0.0     0.0 
. Chronic interstitial nephritis             123      2.5    15     54.5   73.2   16.3   6.5    1.6     51.2     4.9 
. Acute interstitial nephritis                10      0.2    17     70.0   50.0   50.0   0.0    0.0     30.0     0.0 
Hypertensive/large vessel disease            258      5.3    17     57.8   38.4   52.7   3.1    2.7     25.6     4.7 
. Hypertension, (no primary ren. dis.)       237      4.9    17     58.6   35.0   56.1   3.4    2.5     24.9     4.6 
. Renal artery stenosis or occlusion          21      0.4     9     47.6   76.2   14.3   0.0    4.8     33.3     4.8 
. Cholesterol emboli, renal emboli             0        .     .        .      .      .     .      .        .       . 
Cystic/Heriditary/Congenital Diseases      1,259     25.9    11     66.8   72.8   19.0   3.0    1.6     43.7     2.9 
. Polycystic kidneys, adult (dominant)       128      2.6    10     44.5   76.6   14.8   5.5    1.6     46.1     3.1 
. Polycystic, infantile (recessive)           31      0.6     3     41.9   74.2   19.4   6.5    0.0      6.5     9.7 
. Medullary cystic, inc nephronophthisis      40      0.8    13     55.0   85.0   12.5   0.0    2.5     35.0     0.0 
. Alports, other hereditary/familial dis     149      3.1    16     85.9   70.5   21.5   2.7    3.4     40.9     0.7 
. Tuberous sclerosis                           *      0.1    17     66.7   33.3   33.3  33.3    0.0     33.3     0.0 
. Cystinosis                                  39      0.8    12     61.5   92.3    7.7   0.0    0.0     61.5     0.0 
. Primary oxalosis                            13      0.3     0     61.5   84.6    7.7   7.7    0.0     46.2     0.0 
. Fabrys disease                               *      0.0    19    100.0  100.0    0.0   0.0    0.0      0.0     0.0 
. Congenital nephrotic syndrome               41      0.8     1     39.0   65.9   19.5   9.8    2.4     17.1     7.3 
. Drash syndrome, mesangial sclerosis          *      0.1     1     50.0   75.0   25.0   0.0    0.0     25.0     0.0 
. Congenital obstructive uropathy            296      6.1    11     80.7   69.6   19.6   2.7    0.7     50.0     2.4 
. Renal hypoplasia, dysplasia                472      9.7     8     60.8   72.2   20.3   2.1    1.9     43.9     3.8 
. Prune belly syndrome                        42      0.9    10    100.0   73.8   21.4   2.4    0.0     47.6     0.0 
Neoplasms/Tumors                              32      0.7     6     50.0   65.6   21.9   3.1    6.3     15.6    18.8 
. Renal or Urological Neoplasms               31      0.6     6     51.6   64.5   22.6   3.2    6.5     16.1    19.4 
. Multiple myeloma                             0        .     .        .      .      .     .      .        .       . 
. Light chain nephropathy                      0        .     .        .      .      .     .      .        .       . 
. Amyloidosis                                  *      0.0    11      0.0  100.0    0.0   0.0    0.0      0.0     0.0 
Miscellaneous Conditions                     146      3.0    13     58.2   53.4   38.4   0.7    1.4     23.3     7.5 
. Complication post bone marr/other txp        *      0.0    17    100.0  100.0    0.0   0.0    0.0    100.0     0.0 
. Sickle cell disease/anemia or trait         15      0.3    16     66.7    6.7   93.3   0.0    0.0     13.3     0.0 
. AIDS nephropathy                            18      0.4    16     72.2   11.1   83.3   0.0    0.0      0.0    22.2 
. Traumatic/surgical loss of kidney(s)         *      0.1    13     40.0   60.0   20.0   0.0    0.0      0.0     0.0 
. Hepatorenal syndrome                         *      0.0    13    100.0   50.0   50.0   0.0    0.0     50.0     0.0 
. Tubular necrosis (no recovery)              50      1.0    10     54.0   70.0   22.0   2.0    0.0     20.0     6.0 
. Post-Partum Fail, Oth Renal Disorders       55      1.1    13     54.5   63.6   25.5   0.0    3.6     36.4     7.3 
Etiology Uncertain                           418      8.6    15     51.7   64.6   25.8   3.3    1.4     39.5     1.9 
Missing                                      296        .    13     60.5   58.8   27.7   1.7    0.3     66.9     3.4
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.

 
 
Table A.22:  Incidence Of Reported ESRD Therapy
By Detailed Primary Disease And Race
For Pediatric Patients Age < 20, 1992-1996

                                                                                 #                             Native
                                            Total       #       #       #     Native   White   Black   Asian   Amer.
Primary Disease Groups                     Patients   White   Black   Asian   Amer.     (%)     (%)     (%)     (%)

All ESRD, (reference)                       5,155     3,250   1,414    204      79     100.0   100.0   100.0   100.0 
Diabetes                                       83        45      28      *       *       1.5     2.1     2.0     2.6 
. Type 1, juvenile type                        42        22      16      *       0       0.7     1.2     1.0     0.0 
. Type 2, adult-onset or unspec. type          41        23      12      *       *       0.7     0.9     1.0     2.6 
Glomerulonephritis                          1,635       931     537     84      30      30.3    40.3    42.2    38.5 
. Focal glomerulosclerosis, focal GN          515       229     242     18       *       7.4    18.2     9.0     6.4 
. Membranous nephropathy                       23         *      14      0       0       0.3     1.1     0.0     0.0 
. Membranoproliferative GN, types 1&2         130        89      29      *       *       2.9     2.2     2.5     2.6 
. IgA nephropathy, Bergers disease             66        46       *      *       *       1.5     0.6     1.5     6.4 
. IgM nephropathy                               *         *       *      0       0       0.1     0.2     0.0     0.0 
. Rapidly progressive GN                      106        74      12      *       *       2.4     0.9     4.5     7.7 
. Goodpastures Syndrome                        34        30       *      *       0       1.0     0.2     0.5     0.0 
. Post infectious GN, SBE                       *         *       *      0       0       0.2     0.2     0.0     0.0 
. Glomerulonephritis (GN)                     683       403     207     44      12      13.1    15.5    22.1    15.4 
. Other proliferative GN                       65        43      17      *       0       1.4     1.3     2.0     0.0 
Secondary GN/Vasculitis                       470       290     124     33       *       9.4     9.3    16.6     6.4 
. Lupus erythematosus, (SLE nephritis)        257       118     103     22       *       3.8     7.7    11.1     2.6 
. Polyarteritis                                 *         *       *      *       0       0.1     0.1     1.0     0.0 
. Wegeners granulomatosis                      28        24       *      0       0       0.8     0.2     0.0     0.0 
. Henoch-Schonlein syndrome                    50        45       0      *       *       1.5     0.0     1.0     1.3 
. Vasculitis and its derivatives                *         *       *      0       0       0.1     0.3     0.0     0.0 
. Scleroderma                                   *         0       *      0       0       0.0     0.1     0.0     0.0 
. Hemolytic uremic syndrome                    99        83       *      *       *       2.7     0.7     2.0     2.6 
. Nephropathy from heroin /related abuse       17         *       *      *       0       0.3     0.3     1.5     0.0 
. Secondary GN, other                           *         *       0      0       0       0.1     0.0     0.0     0.0 
Interstitial Nephritis/Pyelonephritis         558       425      97     16       *      13.8     7.3     8.0     5.1 
. Chronic pyelonephritis, reflux neph.        120        96      15      *       0       3.1     1.1     1.5     0.0 
. Analgesic abuse                               *         *       0      0       0       0.1     0.0     0.0     0.0 
. Nephropathy caused by other agents           71        58      10      0       *       1.9     0.8     0.0     1.3 
. Nephrolithiasis, Obstruction, Gouty         231       173      47      *       *       5.6     3.5     2.5     1.3 
. Nephrocalcinosis                              *         *       0      0       0       0.0     0.0     0.0     0.0 
. Chronic interstitial nephritis              123        90      20      *       *       2.9     1.5     4.0     2.6 
. Acute interstitial nephritis                 10         *       *      0       0       0.2     0.4     0.0     0.0 
Hypertensive/large vessel disease             258        99     136      *       *       3.2    10.2     4.0     9.0 
. Hypertension, (no primary ren. dis.)        237        83     133      *       *       2.7    10.0     4.0     7.7 
. Renal artery stenosis or occlusion           21        16       *      0       *       0.5     0.2     0.0     1.3 
. Cholesterol emboli, renal emboli              0         0       0      0       0         .       .       .       . 
Cystic/Heriditary/Congenital Diseases       1,259       917     239     38      20      29.8    17.9    19.1    25.6 
. Polycystic kidneys, adult (dominant)        128        98      19      *       *       3.2     1.4     3.5     2.6 
. Polycystic, infantile (recessive)            31        23       *      *       0       0.7     0.5     1.0     0.0 
. Medullary cystic, inc nephronophthisis       40        34       *      0       *       1.1     0.4     0.0     1.3 
. Alports, other hereditary/familial dis      149       105      32      *       *       3.4     2.4     2.0     6.4 
. Tuberous sclerosis                            *         *       *      *       0       0.0     0.1     0.5     0.0 
. Cystinosis                                   39        36       *      0       0       1.2     0.2     0.0     0.0 
. Primary oxalosis                             13        11       *      *       0       0.4     0.1     0.5     0.0 
. Fabrys disease                                *         *       0      0       0       0.0     0.0     0.0     0.0 
. Congenital nephrotic syndrome                41        27       *      *       *       0.9     0.6     2.0     1.3 
. Drash syndrome, mesangial sclerosis           *         *       *      0       0       0.1     0.1     0.0     0.0 
. Congenital obstructive uropathy             296       206      58      *       *       6.7     4.4     4.0     2.6 
. Renal hypoplasia, dysplasia                 472       341      96     10       *      11.1     7.2     5.0    11.5 
. Prune belly syndrome                         42        31       *      *       0       1.0     0.7     0.5     0.0 
Neoplasms/Tumors                               32        21       *      *       *       0.7     0.5     0.5     2.6 
. Renal or Urological Neoplasms                31        20       *      *       *       0.7     0.5     0.5     2.6 
. Multiple myeloma                              0         0       0      0       0         .       .       .       . 
. Light chain nephropathy                       0         0       0      0       0         .       .       .       . 
. Amyloidosis                                   *         *       0      0       0       0.0     0.0     0.0     0.0 
Miscellaneous Conditions                      146        78      56      *       *       2.5     4.2     0.5     2.6 
. Complication post bone marr/other txp         *         *       0      0       0       0.0     0.0     0.0     0.0 
. Sickle cell disease/anemia or trait          15         *      14      0       0       0.0     1.1     0.0     0.0 
. AIDS nephropathy                             18         *      15      0       0       0.1     1.1     0.0     0.0 
. Traumatic/surgical loss of kidney(s)          *         *       *      0       0       0.1     0.1     0.0     0.0 
. Hepatorenal syndrome                          *         *       *      0       0       0.0     0.1     0.0     0.0 
. Tubular necrosis (no recovery)               50        35      11      *       0       1.1     0.8     0.5     0.0 
. Post-Partum Fail, Oth Renal Disorders        55        35      14      0       *       1.1     1.1     0.0     2.6 
Etiology Uncertain                            418       270     108     14       *       8.8     8.1     7.0     7.7 
Missing                                       296       174      82      *       *         .       .       .       . 
* Values for cells with fewer than 10 patients are suppressed.  Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.


Table A.23
 Incidence Counts of Reported ESRD Therapy
By State
After Dropping Territories and Unknown States

                                                                     Year                                           
                               1987     1988     1989     1990     1991     1992     1993     1994     1995     1996
 State                                                                                                              
 Alabama                        644      751      947      847    1,015    1,134    1,092    1,233    1,361    1,432
 Alaska                          28       36       47       36       49       58       53      208      378       69
 Arizona                        508      570      669      695      784      960      920    1,093    1,166    1,229
 Arkansas                       348      377      379      411      501      523      560      673      728      705
 California                   3,919    4,313    4,988    5,390    5,841    5,939    6,210    7,548    8,009    7,861
 Colorado                       312      309      400      403      465      504      506      548      548      643
 Connecticut                    495      467      549      603      655      693      686      788      897      889
 Delaware                       109      127      124      142      161      195      178      199      232      210
 District of Columbia           192      188      309      293      311      336      360      292      416      411
 Florida                      2,166    2,300    2,644    2,841    3,161    3,505    3,546    3,806    4,127    4,535
 Georgia                      1,051    1,132    1,362    1,378    1,628    1,820    1,823    2,071    2,243    2,366
 Hawaii                         206      215      231      276      273      300      320      421      388      371
 Idaho                           86      102      125      141      132      125      137      181      184      192
 Illinois                     1,711    1,782    1,991    2,311    2,658    2,853    3,056    3,380    3,663    3,509
 Indiana                        703      805      863      925      987    1,145    1,216    1,145    1,508    1,488
 Iowa                           282      321      380      416      442      529      506      575      547      562
 Kansas                         277      292      368      398      400      426      423      495      498      554
 Kentucky                       444      476      541      589      695      759      798      732      948      900
 Louisiana                      755      868      995    1,027    1,179    1,309    1,320    1,466    1,625    1,557
 Maine                          110      111      109      146      135      160      154      198      230      204
 Maryland                       709      746      939    1,052    1,145    1,242    1,293    1,271    1,695    1,785
 Massachusetts                  654      765      868      908    1,020    1,164    1,191    1,319    1,419    1,435
 Michigan                     1,215    1,415    1,631    1,747    1,845    2,105    2,191    2,451    2,601    2,835
 Minnesota                      509      500      564      613      655      722      725      856      837      891
 Mississippi                    407      476      557      576      638      745      783      901      916      993
 Missouri                       736      775      887      979    1,065    1,137    1,219    1,323    1,462    1,470
 Montana                         76       71      110      112      139      127      136      146      168      140
 Nebraska                       171      188      221      221      244      290      271      319      341      344
 Nevada                         131      153      168      169      232      236      247      324      342      354
 New Hampshire                   96      105      125      137      145      151      138      169      183      158
 New Jersey                   1,305    1,383    1,567    1,754    1,916    2,092    2,158    2,437    2,668    2,631
 New Mexico                     184      250      242      258      333      311      321      362      434      467
 New York                     2,560    2,797    3,202    3,505    3,723    4,221    4,385    4,966    5,327    5,352
 North Carolina                 994    1,071    1,302    1,361    1,539    1,752    1,863    2,113    2,079    2,304
 North Dakota                    58       73      100      105       94      128      123      145      130      135
 Ohio                         1,451    1,648    1,837    1,938    2,006    2,344    2,415    2,576    3,148    3,263
 Oklahoma                       372      470      481      575      537      645      679      730      806      781
 Oregon                         303      343      397      410      482      471      539      573      566      571
 Pennsylvania                 1,802    1,952    2,262    2,608    2,650    2,906    2,820    3,440    3,775    3,689
 Rhode Island                   113      138      161      187      202      205      231      238      244      253
 South Carolina                 584      671      805      865      923    1,017    1,029    1,279    1,229    1,332
 South Dakota                    92       92       86       94      102      110      120      139      194      181
 Tennessee                      715      707      982      941    1,098    1,180    1,140    1,380    1,479    1,485
 Texas                        2,321    2,653    3,020    3,344    3,634    4,119    4,176    4,609    4,897    5,239
 Utah                           137      182      180      176      182      193      256      238      255      237
 Vermont                         50       52       65       65       92       61       74       80      111       92
 Virginia                       898      967    1,092    1,184    1,403    1,513    1,526    1,597    1,874    2,007
 Washington                     461      490      639      685      730      746      790      917      962      973
 West Virginia                  249      297      278      314      348      370      406      424      513      519
 Wisconsin                      564      669      747      759      840      947      926    1,037    1,079    1,119
 Wyoming                         37       50       44       36       49       39       52       46       69       66
                           -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
                             34,300   37,691   43,580   46,946   51,483   56,562   58,087   65,457   71,499   72,788
 
 
 
 
Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.
* Values for cells with fewer than 10 patients are suppressed.
Includes residents of 50 states and District of Columbia only.



Table A.24
Incidence Rates Per Million Population Of Reported ESRD Therapy
By State
Adjusted By Age, Race and Sex

                                                                     Year                                           
                               1987     1988     1989     1990     1991     1992     1993     1994     1995     1996
 State                                                                                                              
 Alabama                     135.31   165.77   213.76   173.18   204.75   217.70   209.36   244.45   270.16   264.68
 Alaska                      145.57   106.47   178.75   123.09   144.92   177.74   192.21   736.18  1252.83   210.98
 Arizona                     170.17   192.70   217.58   206.71   237.99   286.99   253.01   290.03   287.46   306.33
 Arkansas                    135.43   157.58   154.94   161.58   202.64   203.99   212.59   251.76   276.47   256.16
 California                  164.54   177.09   200.11   214.91   228.64   226.24   227.94   273.86   281.13   269.55
 Colorado                    125.51   117.50   167.24   156.87   186.78   183.86   184.39   191.03   191.58   207.43
 Connecticut                 188.46   160.34   186.23   197.57   217.31   231.68   224.35   257.72   289.09   280.29
 Delaware                    174.96   183.87   197.65   216.46   233.11   280.48   244.61   254.71   308.32   261.21
 District of Columbia        124.60   215.55   219.29   197.15   174.50   188.26   228.52   221.50   300.20   224.26
 Florida                     164.32   165.33   187.63   194.56   208.24   225.47   225.42   231.41   250.20   266.03
 Georgia                     157.49   157.87   192.30   180.73   212.46   231.30   230.49   256.13   326.28   341.66
 Hawaii                      117.71   103.10   222.57   143.89   126.37   155.73   165.81   192.17   159.07   133.48
 Idaho                        84.96   101.38   169.44   143.75   174.61   250.65   248.86   308.87   219.31   224.17
 Illinois                    155.19   157.93   176.40   202.33   228.77   246.78   258.28   282.87   306.02   289.72
 Indiana                     155.89   167.26   191.03   198.56   202.75   235.14   256.46   244.82   310.74   292.84
 Iowa                        189.64   159.00   197.32   222.25   208.76   264.66   230.81   295.51   278.75   315.29
 Kansas                      133.87   143.65   174.64   194.55   197.94   205.18   207.06   230.39   240.55   271.30
 Kentucky                    141.45   156.00   215.55   185.47   216.59   257.16   249.85   235.11   288.30   258.98
 Louisiana                   170.30   184.15   200.22   210.68   245.61   267.28   259.98   285.94   310.73   284.88
 Maine                       105.19   361.96   145.09   160.49   184.82   133.75   109.95   304.83   282.03   309.57
 Maryland                    136.73   138.56   171.46   192.62   204.54   219.45   222.31   213.64   276.16   283.12
 Massachusetts               131.62   152.32   166.02   174.72   189.89   218.39   218.77   243.35   267.03   264.76
 Michigan                    142.26   159.17   184.34   194.75   203.44   227.24   233.08   264.32   275.64   291.02
 Minnesota                   164.24   179.25   180.61   205.32   203.67   217.01   219.54   262.27   275.58   265.64
 Mississippi                 133.65   156.42   193.69   172.28   205.23   224.28   224.66   295.00   300.86   278.66
 Missouri                    155.71   161.02   198.26   200.76   217.11   229.64   243.59   258.79   287.70   295.76
 Montana                      87.51   154.26   124.12   302.62   265.27   139.29   144.53   308.04   359.23   138.72
 Nebraska                    170.62   168.26   190.56   181.56   219.74   231.92   226.38   263.61   261.30   286.78
 Nevada                      157.71   169.17   199.37   170.15   211.68   196.50   203.54   248.25   245.05   231.70
 New Hampshire               177.98   200.44   194.49   202.94   182.59   169.02   157.49   241.58   196.84   190.53
 New Jersey                  167.80   173.49   197.01   219.36   235.05   254.22   258.53   287.24   310.88   303.42
 New Mexico                  142.42   195.58   196.56   201.37   230.12   217.02   213.01   230.41   277.99   287.40
 New York                    137.53   148.06   167.98   181.66   192.99   216.19   222.05   248.60   262.47   262.64
 North Carolina              133.52   141.51   170.62   173.69   195.32   215.17   226.26   250.91   268.15   291.01
 North Dakota                 88.53   110.18   817.76   193.94   136.26   204.49   784.04   401.31  1025.94   219.69
 Ohio                        147.95   164.88   195.40   191.90   192.18   223.47   227.07   242.26   295.00   298.05
 Oklahoma                    123.47   156.93   160.73   188.47   174.79   205.44   220.07   229.73   250.43   239.76
 Oregon                      161.58   156.97   195.21   168.62   222.30   184.08   218.94   243.50   233.06   229.72
 Pennsylvania                159.23   165.69   215.59   227.85   223.66   239.76   232.40   287.72   317.06   294.43
 Rhode Island                123.70   157.37   209.96   234.11   216.99   231.15   237.72   278.51   290.39   293.92
 South Carolina              153.43   158.21   194.12   208.15   204.61   250.05   228.06   277.69   407.37   439.28
 South Dakota                121.94   152.42   110.16   478.73   446.54   135.91   146.44   189.14   268.01   267.74
 Tennessee                   149.20   155.55   234.64   191.70   213.78   232.14   218.52   256.23   282.02   262.45
 Texas                       171.36   193.46   211.96   225.99   243.85   268.77   266.59   286.34   300.68   313.03
 Utah                        102.56   197.08   128.17   119.11   178.97   163.27   292.56   178.90   191.57   208.07
 Vermont                     191.44   268.34   608.48   103.99   271.40   164.58   198.17   477.46   338.37   238.73
 Virginia                    144.82   153.00   168.22   180.21   209.16   221.06   220.63   223.38   258.53   269.19
 Washington                  129.68   134.15   170.85   185.84   188.14   200.43   198.11   216.31   224.99   225.10
 West Virginia               182.88   188.25   169.72   218.76   221.22   238.73   260.70   265.87   349.75   310.60
 Wisconsin                   161.67   181.93   195.79   203.10   216.05   249.71   239.54   256.33   278.17   277.85
 Wyoming                     133.76   176.28   167.21   124.65   297.29   131.29   248.04   129.18   152.53   247.59
 
 
  
 
 
 

Includes all patients: residents of the 50 states, the District of Colulmbia, Puerto Rico and the Territories.
* Values for cells with fewer than 10 patients are suppressed.
Includes residents of 50 states and District of Columbia only.
Rates per million based on July 1,  U.S. resident population by state or ESRD Network.  The standard population is July 1, 1995, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. 






Reference Tables:  Incidence Of Reported ESRD Therapy   USRDS 1998 Annual Data Report

USRDS  Patient Database Updated From HCFA REBUS September 1997.  Quality Control Filters Applied.       
See section introduction and Chapter XIII discussion of the database and of the methodologies used.